.Atea Pharmaceuticals' antiviral has fallen short another COVID-19 test, but the biotech still holds...
.Neurocrine Biosciences' mental illness course pivot has neglected. The biotech was actually incapab...
.Sanofi has actually created a late entry to the radioligand celebration, paying for 100 thousand eu...
.After F2G's first effort to acquire a brand-new class of antifungal to market was derailed due to t...
.Moderna has actually sworn to cut R&D costs by $1.1 billion by 2027. The selection to shrink the...
.Merely 4 months after Sanofi wager $80 thousand in upfront cash money on Fulcrum Rehabs' losmapimod...
.Cancer cells firm Oncternal Therapeutics is actually folding all its own professional tests and lay...
.Roche is storing out chances that its own injectable weight problems possibility might eventually d...
.Novo Nordisk has elevated the cover on a period 1 trial of its own dental amylin and also GLP-1 rec...
.Simply a few short full weeks after gaining an FDA Fast lane tag for its investigational BTK degrad...